Welcome to CardioPolymers
NOTICE: On June 2, 2010, CardioPolymers, Inc. was acquired by LoneStar Heart, Inc. CardioPolymers is now a fully owned subsidiary of LoneStar Heart, Inc.
CardioPolymers is developing novel biocompatible polymer implant therapies to treat chronic heart failure, mitral valve regurgitation and post-operative atrial fibrillation.
News
June 2010
On June 2, 2010, CardioPolymers, Inc. completed a merger with LoneStar Heart, Inc. and became a fully owned subsidiary of that company. With its new parent, CardioPolymers will continue to develop its lead product for Congestive Heart Failure while benefiting from a significant technology pipeline. Check back for more details on the merger in the near future...

